Analysts' average 12-month price target for Zoetis is $92.
Get informed when a big investor buys or sells
+ Follow$73.68
10 analysts in the last 4 months
High: $115 | Low: $80
No recommendations in the last 4 months.
Zoetis (ZTS) currently reports a target price of $92. Use the charts on this page to explore Zoetis's target price history and peer comparisons.
Analysts' average 12-month price target for Zoetis is $92, about 24.6% upside from the current share price of $73.68. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.
Start with the current target price of $92, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Zoetis, and consider following ZTS for alerts when major investors trade the stock.
Zoetis is classified in the Healthcare sector. On target price, it currently shows $92. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ZTS with unrelated industries.